来自MSN1 天
Cantor Fitzgerald Initiates Coverage of GH Research (GHRS) with Overweight Recommendation
Fintel reports that on February 13, 2025, Cantor Fitzgerald initiated coverage of GH Research (NasdaqGM:GHRS) with a ...
Yahoo Finance3 天
GH Research PLC (GHRS)
After hours: February 12 at 6:46:26 PM EST Loading Chart for GHRS ...
GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat ...
Key Insights GH Research's significant insider ownership suggests inherent interests in company's expansion A total ...
GH Research initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of GH Research (GHRS) with an Overweight rating and $14 price target Maximize Your Portfolio with Data ...
Cantor Fitzgerald给予GH Research"增持"评级，目标价14美元
周四 - Cantor Fitzgerald对GH Research PLC (NASDAQ: GHRS )给予"增持"评级，目标价设定为14.00美元。这一新的评级基于GHRS的GH001（一种吸入式5-MeO-DMT疗法）有望成为难治性抑郁症（TRD）标准疗法的潜力。Cantor ...
Cantor Fitzgerald sets GH Research stock Overweight, $14 target
GH Research PLC (NASDAQ:GHRS) has received an Overweight rating from Cantor Fitzgerald, with a price target set at $14.00. The new coverage is based on the potential of GHRS's GH001, an inhaled ...
中国战略预警雷达曝光 可侦测远程导弹 部署地有玄机|军情观察室
中国战略预警雷达曝光 可侦测远程导弹 部署地有玄机|军情观察室 ...
Atai CEO Rao optimistic about psychedelic therapies despite Lykos setback
FDA's rejection of MDMA therapy for PTSD doesn't dampen hopes for other psychedelic treatments. Read more here.